Metabolic classification of bladder cancer based on multi-omics integrated analysis to predict patient prognosis and treatment response

被引:0
|
作者
Chaozhi Tang
Meng Yu
Jiakang Ma
Yuyan Zhu
机构
[1] The First Hospital of China Medical University,Department of Urology
[2] China Medical University,Department of Laboratory Animal Science
[3] Key Laboratory of Transgenetic Animal Research,Department of Oncology
[4] Liaoning Province,undefined
[5] China Medical University,undefined
[6] The Second Affiliated Hospital of Zhengzhou University,undefined
关键词
Metabolic classification; Bladder cancer; Prognosis; Immunotherapy; Chemotherapy;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 50 条
  • [1] Metabolic classification of bladder cancer based on multi-omics integrated analysis to predict patient prognosis and treatment response
    Tang, Chaozhi
    Yu, Meng
    Ma, Jiakang
    Zhu, Yuyan
    JOURNAL OF TRANSLATIONAL MEDICINE, 2021, 19 (01)
  • [2] Multi-omics analysis reveals critical metabolic regulators in bladder cancer
    Wei, Chengcheng
    Deng, Changqi
    Dong, Rui
    Hou, Yaxin
    Wang, Miao
    Wang, Liang
    Hou, Teng
    Chen, Zhaohui
    INTERNATIONAL UROLOGY AND NEPHROLOGY, 2024, 56 (03) : 923 - 934
  • [3] Multi-omics analysis reveals critical metabolic regulators in bladder cancer
    Chengcheng Wei
    Changqi Deng
    Rui Dong
    Yaxin Hou
    Miao Wang
    Liang Wang
    Teng Hou
    Zhaohui Chen
    International Urology and Nephrology, 2024, 56 : 923 - 934
  • [4] Molecular Correlates of Cisplatin-based Chemotherapy Response in Muscle Invasive Bladder Cancer by Integrated Multi-omics Analysis
    Taber, A.
    Christensen, E.
    Lamy, P.
    Nordentoft, I
    Prip, F. F.
    Lindskrog, C., V
    Birkenkamp-Demtroder, K.
    Okholm, T. L. H.
    Knudsen, M.
    Pedersen, J. S.
    Steiniche, T.
    Agerboek, M.
    Jensen, J. B.
    Dyrskjot, L.
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2020, 38 (12) : 899 - 899
  • [5] Molecular correlates of cisplatin-based chemotherapy response in muscle invasive bladder cancer by integrated multi-omics analysis
    Taber, Ann
    Christensen, Emil
    Lamy, Philippe
    Nordentoft, Iver
    Prip, Frederik
    Lindskrog, Sia Viborg
    Birkenkamp-Demtroeder, Karin
    Okholm, Trine Line Hauge
    Knudsen, Michael
    Pedersen, Jakob Skou
    Steiniche, Torben
    Agerbaek, Mads
    Jensen, Jorgen Bjerggaard
    Dyrskjot, Lars
    NATURE COMMUNICATIONS, 2020, 11 (01)
  • [6] Molecular correlates of cisplatin-based chemotherapy response in muscle invasive bladder cancer by integrated multi-omics analysis
    Ann Taber
    Emil Christensen
    Philippe Lamy
    Iver Nordentoft
    Frederik Prip
    Sia Viborg Lindskrog
    Karin Birkenkamp-Demtröder
    Trine Line Hauge Okholm
    Michael Knudsen
    Jakob Skou Pedersen
    Torben Steiniche
    Mads Agerbæk
    Jørgen Bjerggaard Jensen
    Lars Dyrskjøt
    Nature Communications, 11
  • [7] Integrated Multi-Omics Analysis Model to Identify Biomarkers Associated With Prognosis of Breast Cancer
    Fan, Yeye
    Kao, Chunyu
    Yang, Fu
    Wang, Fei
    Yin, Gengshen
    Wang, Yongjiu
    He, Yong
    Ji, Jiadong
    Liu, Liyuan
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [8] Integrated multi-omics analysis reveals systemic and localized metabolic disruptions in colorectal cancer
    Patti, Gary
    Stancliffe, Ethan
    Richardson, Adam
    Mehta, Ashima
    Gandhi, Monil
    Cho, Kevin
    CANCER RESEARCH, 2024, 84 (06)
  • [9] Author Correction: Molecular correlates of cisplatin-based chemotherapy response in muscle invasive bladder cancer by integrated multi-omics analysis
    Ann Taber
    Emil Christensen
    Philippe Lamy
    Iver Nordentoft
    Frederik Prip
    Sia Viborg Lindskrog
    Karin Birkenkamp-Demtröder
    Trine Line Hauge Okholm
    Michael Knudsen
    Jakob Skou Pedersen
    Torben Steiniche
    Mads Agerbæk
    Jørgen Bjerggaard Jensen
    Lars Dyrskjøt
    Nature Communications, 13
  • [10] Comprehensive Analysis of Metabolic Genes in Breast Cancer Based on Multi-Omics Data
    Hua, Yu
    Gao, Lihong
    Li, Xiaobo
    PATHOLOGY & ONCOLOGY RESEARCH, 2021, 27